Successfully treated HIV-infected patients have differential expression of NK cell receptors (NKp46 and NKp30) according to AIDS status at presentation

Immunology Letters

Volumn 152, Issue 1, 2013, Pages 16-24

  Bisio, Francesca ^a   Bozzano, Federica ^b   Marras, Francesco ^a   Di Biagio, Antonio ^c   Moretta, Lorenzo ^a,b   De Maria, Andrea ^b,c  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

AIDS; HIV; NKp30; NKp46; Opportunistic infection

Indexed keywords

CD69 ANTIGEN; HLA DR ANTIGEN; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN EXPRESSION; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MONOCYTE; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL ADHESION MOLECULES; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV; HUMANS; IMMUNITY, INNATE; KILLER CELLS, NATURAL; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; TREATMENT OUTCOME;

EID: 84877682470     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2013.03.003     Document Type: Article

References (39)

1. Masur H., Ognibene F., Yarchoan R., Shelhamer J., Baird B., Travis W., et al. CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann Intern Med 1989, 111:223-231.
2. Crowe S., Carlin J., Stewart K., Lucas C., Hoy J. Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. J Acquir Immune Defic Syndr 1991, 4:770-776.
3. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. Available at [accessed on 07.12.12]. http://www.aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf.
4. De Maria A., Cossarizza A. CD4saurus Rex &HIVelociraptor vs. development of clinically useful immunological markers: a Jurassic tale of frozen evolution. J Transl Med 2011, 16:93. 10.1186/1479-5876-9-93.
5. Ironson G., Balbin E., Solomon G., Fahey J., Klimas N., Schneiderman N., et al. Relative preservation of natural killer cell cytotoxicity and number in healthy AIDS patients with low CD4 cell counts. AIDS 2001, 15:2065-2073.
6. Vivier E., Raulet D.H., Moretta A., Caligiuri M.A., Zitvogel L., Lanier L.L., et al. Innate or adaptive immunity? The example of natural killer cells. Science 2011, 331:44-49.
7. De Maria A., Moretta L. NK cell function in HIV-1 infection. Curr HIV Res 2008, 6:433-440.
8. De Maria A., Moretta L. Revisited function of human NK cell subsets. Cell Cycle 2011, 10:1178-1179.
9. Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol 2002, 2:957-964.
10. - subset. AIDS Res Hum Retroviruses 1990, 6:1451-1457.
11. Ratcliffe L.T., Lukey P.T., MacKenzie C.R., Ress S.R., Reduced N.K. activity correlates with active disease in HIV patients with multidrug-resistant pulmonary tuberculosis. Clin Exp Immunol 1994, 97:373-379.
12. Ullum H., Cozzi Lepri A., Aladdin H., Katzenstein T., Victor J., Phillips A.N., et al. Natural immunity and HIV disease progression. AIDS 1999, 13:557-563.
13. De Maria A., Fogli M., Costa P., Murdaca G., Puppo F., Mavilio D., et al. The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44). Eur J Immunol 2003, 33:2410-2418.
14. Kottilil S., Chun T.W., Moir S., Liu S., McLaughlin M., Hallahan C.W., et al. Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function. J Infect Dis 2003, 187:1038-1045.
15. Mavilio D., Benjamin J., Daucher M., Lombardo G., Kottilil S., Planta M.A., et al. Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. Proc Natl Acad Sci U S A 2003, 100:15011-15016.
16. Kottilil S., Shin K., Planta M., McLaughlin M., Hallahan C.W., Ghany M., et al. Expression of chemokine and inhibitory receptors on natural killer cells: effect of immune activation and HIV viremia. J Infect Dis 2004, 189:1193-1198.
17. Alter G., Malenfant J.M., Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 2004, 294:15-22.
18. Mandelboim O., Lieberman N., Lev M., Paul L., Arnon T.I., Bushkin Y., et al. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 2001, 409:1055-1060.
19. Hershkovitz O., Rosental B., Rosenberg L.A., Navarro-Sanchez M.E., Jivov S., Zilka A., et al. NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells. J Immunol 2009, 183:2610-2621.
20. Marras F., Bozzano F., De Maria A. Involvement of activating NK cell receptors and their modulation in pathogen immunity. J Biomed Biotechnol 2011, 2011:152430.
21. Salazar-Gonzalez J.F., Martinez-Maza O., Nishanian P., Aziz N., Shen L.P., Grosser S., et al. Increased immune activation precedes the inflection point of CD4 T cells and the increased serum virus load in human immunodeficiency virus infection. J Infect Dis 1998, 178:423-430.
22. Hunt P.W., Brenchley J., Sinclair E., McCune J.M., Roland M., Page-Shafer K., et al. Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis 2008, 197:126-133.
23. Kuller L.H., Tracy R., Belloso W., De Wit S., Drummond F., Lane H.C., et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 2008, 5:e203.
24. Rodger A.J., Fox Z., Lundgren J.D., Kuller L.H., Boesecke C., Gey D., et al. Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection. J Infect Dis 2009, 200:973-983.
25. Lichtfuss G.F., Cheng W.J., Farsakoglu Y., Paukovics G., Rajasuriar R., Velayudham P., et al. Virologically suppressed HIV patients show activation of NK cells and persistent innate immune activation. J Immunol 2012, 189:1491-1499.
26. Fogli M., Costa P., Murdaca G., Setti M., Mingari M.C., Moretta L., et al. Significant NK cell activation associated with decreased cytolytic function in peripheral blood of HIV-1-infected patients. Eur J Immunol 2004, 34:2313-2321.
27. Vargas-Inchaustegui D.A., Xiao P., Tuero I., Patterson L.J., Robert-Guroff M. NK and CD4+ T cell cooperative immune responses correlate with control of disease in a macaque simian immunodeficiency virus infection model. J Immunol 2012, 189:1878-1885.
28. Cerboni C., Neri F., Casartelli N., Zingoni A., Cosman D., Rossi P., et al. Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity. J Gen Virol 2007, 88:242-250.
29. Matusali G., Potestà M., Santoni A., Cerboni C., Doria M. The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR. J Virol 2012, 86:4496-4504.
30. Fogli M., Mavilio D., Brunetta E., Varchetta S., Ata K., Roby G., et al. Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals. PLoS Pathog 2008, 4:e1000101.
31. Ward J., Bonaparte M., Sacks J., Guterman J., Fogli M., Mavilio D., et al. HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts. Blood 2007, 110:1207-1214.
32. Reymond N., Imbert A.M., Devilard E., Fabre S., Chabannon C., Xerri L., et al. DNAM-1 and PVR regulate monocyte migration through endothelial junctions. J Exp Med 2004, 199:1331-1341.
33. Xu Z., Jin B. A novel interface consisting of homologous immunoglobulin superfamily members with multiple functions. Cell Mol Immunol 2010, 7:11-19.
34. McCann F.E., Eissmann P., Onfelt B., Leung R., Davis D.M. The activating NKG2D ligand MHC class I-related chain A transfers from target cells to NK cells in a manner that allows functional consequences. J Immunol 2007, 178:3418-3426.
35. Cheney E.E., Wise E.L., Bui J.D., Schreiber R.D., Carayannopoulos L.N., Spitzer D., et al. A dual function of NKG2D ligands in NK-cell activation. Eur J Immunol 2012, 42:2452-2458.
36. Bottino C., Castriconi R., Pende D., Rivera P., Nanni M., Carnemolla B., et al. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J Exp Med 2003, 198:557-567.
37. Tahara-Hanaoka S., Shibuya K., Onoda Y., Zhang H., Yamazaki S., Miyamoto A., et al. A Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112). Int Immunol 2004, 16:533-538.
38. Maurer T., Ponte M., Leslie K. HIV-associated Kaposi's Sarcoma with a High CD4 count and a low viral load. NEJM 2007, 357:1352-1353.
39. Guech-Ongey M., Simard E.P., Anderson W.F., Engels E.A., Bhatia K., Devesa S.S., et al. AIDS-related Burkitt lymphoma in the United States: what do age and CD4 lymphocyte patterns tell us about etiology and/or biology?. Blood 2010, 116:5600-5604.